Arcutis Biotherapeutics (ARQT) EBITDA (2019 - 2026)
Arcutis Biotherapeutics (ARQT) EBITDA from Mar 31, 2019 to Mar 31, 2026. The TTM Arcutis Biotherapeutics (ARQT) EBITDA is $6.02M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Annual EBITDA change of Arcutis Biotherapeutics (ARQT)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$6.83M | -40.76% |
| 2025 | -$12M | -90.98% |
| 2024 | -$128M | -46.82% |
| 2023 | -$240M | -20.17% |
| 2022 | -$301M | +46.07% |
| 2021 | -$206M | +50.94% |
| 2020 | -$137M | +217.05% |
| 2019 | -$43M | +118.25% |
| 2018 | -$20M | N/A |